APT Medical Inc. (SHA:688617)

APT Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,266	2,049	1,642	1,204	822.86	477.94
Other Revenue	12.9	16.62	8.49	11.55	5.82	1.5
Revenue	2,279	2,066	1,650	1,216	828.69	479.44
Revenue Growth (YoY)	22.30%	25.18%	35.71%	46.74%	72.85%	18.68%
Cost of Revenue	630.44	579.89	486.14	354.04	259.08	142.13
Gross Profit	1,648	1,486	1,164	861.98	569.61	337.3
Selling, General & Admin	506.79	464.34	386.96	307.57	251.43	152.5
Research & Development	313.88	290.54	237.92	174.88	134.88	71.9
Other Operating Expenses	35.27	15.22	14.52	13.75	8.14	6.14
Operating Expenses	858.63	772.32	639.21	496.99	393.93	230.82
Operating Income	789.58	713.59	524.86	364.99	175.68	106.48
Interest Expense	-1.38	-2.01	-3.69	-1.45	-1.63	-0.83
Interest & Investment Income	25.69	25.23	27.74	23.94	13.26	1.21
Currency Exchange Gain (Loss)	3.91	2.83	2.66	1.17	-1	-0.43
Other Non Operating Income (Expenses)	0.46	-0.82	-0.04	-0.49	-0.5	-0.33
EBT Excluding Unusual Items	818.26	738.83	551.53	388.16	185.81	106.09
Impairment of Goodwill	-	-	-3.84	-	-	-
Gain (Loss) on Sale of Investments	-17.32	-16.7	-	0.34	21.72	-0.07
Gain (Loss) on Sale of Assets	0.23	0.25	11.97	0.06	0.02	-0.23
Asset Writedown	-0.95	-0.83	-0.12	-10.68	-3.57	-
Other Unusual Items	36.81	24.42	36.83	17.25	17.58	15.42
Pretax Income	837.04	745.97	596.37	395.13	221.55	121.21
Income Tax Expense	98.02	87.8	74.24	54.98	26.7	17.02
Earnings From Continuing Operations	739.01	658.17	522.13	340.16	194.85	104.19
Minority Interest in Earnings	16.74	14.98	11.79	17.86	13.07	6.58
Net Income	755.75	673.15	533.92	358.02	207.92	110.78
Net Income to Common	755.75	673.15	533.92	358.02	207.92	110.78
Net Income Growth	22.07%	26.08%	49.13%	72.19%	87.70%	34.15%
Shares Outstanding (Basic)	141	140	140	140	137	105
Shares Outstanding (Diluted)	141	141	142	142	138	105
Shares Change (YoY)	0.08%	-0.52%	-0.16%	2.99%	31.45%	-0.29%
EPS (Basic)	5.37	4.80	3.82	2.56	1.52	1.06
EPS (Diluted)	5.35	4.77	3.77	2.52	1.51	1.06
EPS Growth	21.97%	26.74%	49.38%	67.20%	42.79%	34.54%
Free Cash Flow	502.96	93.15	487.03	224.25	14.01	104.04
Free Cash Flow Per Share	3.56	0.66	3.44	1.58	0.10	0.99
Dividend Per Share	1.207	1.207	0.951	0.785	0.476	0.238
Dividend Growth	26.88%	26.88%	21.20%	65.01%	100.00%	-
Gross Margin	72.33%	71.93%	70.54%	70.88%	68.74%	70.35%
Operating Margin	34.65%	34.54%	31.81%	30.01%	21.20%	22.21%
Profit Margin	33.17%	32.58%	32.36%	29.44%	25.09%	23.11%
Free Cash Flow Margin	22.07%	4.51%	29.51%	18.44%	1.69%	21.70%
EBITDA	883.11	790.25	580.9	405.69	203.49	126.49
EBITDA Margin	38.76%	38.25%	35.20%	33.36%	24.56%	26.38%
D&A For EBITDA	93.53	76.66	56.04	40.7	27.81	20
EBIT	789.58	713.59	524.86	364.99	175.68	106.48
EBIT Margin	34.65%	34.54%	31.80%	30.01%	21.20%	22.21%
Effective Tax Rate	11.71%	11.77%	12.45%	13.91%	12.05%	14.04%
Revenue as Reported	2,279	2,066	1,650	1,216	828.69	479.44

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.